Evidence map›Paper›PMID 32460147›Full record

ArticleSeminars in arthritis and rheumatism2020

Patterns of clinical presentation in Takayasu's arteritis.

Kaitlin A Quinn, K Bates Gribbons, Simon Carette, David Cuthbertson, Nader A Khalidi, Curry L Koening, Carol A Langford, Carol A McAlear, Paul A Monach, Larry W Moreland and 8 more

Open access · greenAbstract readMulticenter Study
In one paragraph

Article in Seminars in arthritis and rheumatism, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 25 papers.

0numbers the graph read from it
0cells of the map it votes in
25citing papers in PubMed
3.8field-weighted citation impact, top 5% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

25 citing papers in PubMed, 52 citations in OpenAlex.

  1. Article
  2. Article
  3. Biomarkers in Primary Systemic Vasculitides: Narrative Review.International journal of molecular sciences · 2026
    Review
  4. Article
  5. Review
  6. Review
  7. Article
  8. Carotidynia as the First Manifestation of Takayasu Arteritis: Report of Two Cases and a Brief Review of Literature.Indian journal of otolaryngology and head and neck surgery : official publication of the Association of Otolaryngologists of India · 2024
    Article
  9. Article
  10. Review
  11. Review
  12. Risk factors and prognosis of depression in Takayasu arteritis patients.Therapeutic advances in musculoskeletal disease · 2024
    Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Review
  18. Article
  19. Article
  20. Observational
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

18 authors at 12 institutions in 1 country.

Kaitlin A QuinnDivision of Rheumatology, MedStar Georgetown University Hospital, Washington DC, USA; Systemic Autoimmunity Branch, National Institutes of Health, NIAMS, Bethesda, MD, USA. Electronic address: Kaitlin.quinn@nih.gov.
K Bates GribbonsSystemic Autoimmunity Branch, National Institutes of Health, NIAMS, Bethesda, MD, USA.
Simon CaretteDivision of Rheumatology, Mount Sinai Hospital, University of Toronto, Toronto, CA.
David CuthbertsonDepartment of Biostatistics, University of South Florida, Tampa, FL, USA.
Nader A KhalidiDivision of Rheumatology, McMaster University, Hamilton, CA.
Curry L KoeningDivision of Rheumatology, University of Utah, Salt Lake City, UT, USA.
Carol A LangfordDepartment of Rheumatic and Immunologic Diseases, Cleveland Clinic Foundation, Cleveland, OH, USA.
Carol A McAlearDivision of Rheumatology, Department of Biostatistics, Epidemiology, and Informatics, University of Pennsylvania, Philadelphia, PA, USA.
Paul A MonachDivision of Rheumatology, VA Boston Healthcare System, Boston, MA, USA.
Larry W MorelandDivision of Rheumatology, University of Pittsburgh, PA, USA.
Christian PagnouxDivision of Rheumatology, Mount Sinai Hospital, University of Toronto, Toronto, CA.
Philip SeoDivision of Rheumatology, Johns Hopkins University, MD, USA.
Antoine G SreihDivision of Rheumatology, Department of Biostatistics, Epidemiology, and Informatics, University of Pennsylvania, Philadelphia, PA, USA.
Kenneth J WarringtonDivision of Rheumatology, Mayo Clinic, Rochester, MN, USA.
Steven R YtterbergDivision of Rheumatology, Mayo Clinic, Rochester, MN, USA.
Elaine NovakovichSystemic Autoimmunity Branch, National Institutes of Health, NIAMS, Bethesda, MD, USA.
Peter A MerkelDivision of Rheumatology, Department of Biostatistics, Epidemiology, and Informatics, University of Pennsylvania, Philadelphia, PA, USA.
Peter C GraysonSystemic Autoimmunity Branch, National Institutes of Health, NIAMS, Bethesda, MD, USA.
University of Pennsylvania · USMayo Clinic in Arizona · USMount Sinai Hospital · USNational Institutes of Health · USCleveland Clinic · USJohns Hopkins University · USMedStar Georgetown University Hospital · USNational Institute of Arthritis and Musculoskeletal and Skin Diseases · USUniversity of Pittsburgh · USUniversity of South Florida · USUniversity of Utah · USVA Boston Healthcare System · US

Funding

Vasculitis and Translational MedicineZIAAR041204 · NIAMS · NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES · PI GRAYSON, PETER · 2015 to 2025
$15.4M
VCRC-VF FellowshipU54AR057319 · NIAMS · UNIVERSITY OF PENNSYLVANIA · PI MERKEL, PETER A · 2009 to 2020
$12.5M
VASCULITIS CLINICAL RESEARCH NETWORK (VCRN): RARE DISEASEU54RR019497 · NCRR · BOSTON UNIVERSITY MEDICAL CAMPUS · PI MERKEL, PETER A · 2003 to 2008
$6.1M
Intramural NIH HHS Z99 AR999999NCRR NIH HHS U54 RR019497NIAMS NIH HHS U54 AR057319
6 · The paper itself

Abstract

objectiveTakayasu's arteritis (TAK) is a clinically heterogenous disease. Patterns of clinical presentation in TAK at diagnosis have not been well described, and a "triphasic pattern" of constitutional symptoms evolving into vascular inflammation and fibrosis has been reported but never systematically evaluated.

methodsPatients with TAK were prospectively recruited from the National Institutes of Health (NIH) and the Vasculitis Clinical Research Consortium (VCRC). Based on clinical presentation at diagnosis, patients were divided into five categories: (1) constitutional symptoms alone, (2) carotidynia, (3) other vascular-associated symptoms, (4) major ischemic event, or (5) asymptomatic. Associated clinical characteristics were evaluated in each category. Preceding symptoms were also assessed to determine the presence of a triphasic disease pattern.

resultsA total of 275 patients with TAK were included (VCRC=208; NIH=67). Similar heterogeneity of clinical presentation was identified in each cohort: constitutional symptoms (8%), carotidynia (13-15%), other vascular symptoms (43-47%), major ischemic event (28-30%), and asymptomatic (2-6%). An increased relative proportion of males was seen in patients who presented with constitutional symptoms or were asymptomatic at diagnosis (p<0.01). Patients who presented with constitutional symptoms and major ischemic events were youngest at diagnosis. Patients in the asymptomatic group were oldest at diagnosis and often were not treated (p<0.01). Relapse was most frequent in patients who presented with carotidynia (p<0.01). A minority of patients (19%) who presented with a major ischemic event reported a triphasic pattern of disease.

conclusionThere are diverse clinical presentations at diagnosis in TAK. Patients do not necessarily progress sequentially through phases of disease.

Indexed as

AdultDisease ProgressionFemaleHumansMaleProspective StudiesTakayasu ArteritisEpidemiologyObservational cohortTakayasu's arteritisVasculitis

Identifiers

PMID32460147
PMCPMC12224341
OpenAlexW3026622626

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.